MENZO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 5.009
EU - Europa 2.531
AS - Asia 1.490
SA - Sud America 314
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 9.467
Nazione #
US - Stati Uniti d'America 4.959
SG - Singapore 599
UA - Ucraina 465
IT - Italia 428
CN - Cina 322
RU - Federazione Russa 298
DE - Germania 282
IE - Irlanda 282
BR - Brasile 271
HK - Hong Kong 210
SE - Svezia 201
DK - Danimarca 171
FI - Finlandia 119
TR - Turchia 111
GB - Regno Unito 99
KR - Corea 91
FR - Francia 77
CI - Costa d'Avorio 69
VN - Vietnam 67
NL - Olanda 24
CA - Canada 23
MX - Messico 23
AT - Austria 22
AR - Argentina 21
IN - India 21
MA - Marocco 20
PL - Polonia 19
BD - Bangladesh 16
BE - Belgio 16
ZA - Sudafrica 13
ES - Italia 8
JP - Giappone 7
ID - Indonesia 6
CO - Colombia 5
EC - Ecuador 5
EU - Europa 5
IQ - Iraq 5
NP - Nepal 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
RO - Romania 4
CM - Camerun 3
IL - Israele 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
A1 - Anonimo 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
PE - Perù 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MN - Mongolia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.467
Città #
Jacksonville 479
Ashburn 452
Chandler 441
Fairfield 376
Singapore 323
Des Moines 303
Dublin 282
Dallas 250
Boardman 248
Hong Kong 210
Wilmington 190
Woodbridge 165
Houston 157
New York 144
Seattle 144
Ann Arbor 119
Lawrence 107
Princeton 107
San Mateo 107
Cambridge 100
Los Angeles 77
Redmond 70
Abidjan 69
Beijing 62
Hefei 62
The Dalles 58
Ancona 56
San Diego 52
Moscow 51
Buffalo 46
Civitanova Marche 39
Munich 39
Centro 35
Chicago 31
London 29
São Paulo 25
Ho Chi Minh City 24
Helsinki 20
Turin 20
Milan 18
Brussels 16
Marche 16
Nuremberg 16
Warsaw 16
Shanghai 15
Rome 14
Wuhan 14
Guangzhou 13
Hanoi 12
Mexico City 12
Washington 12
Appignano 11
Council Bluffs 11
Rio de Janeiro 11
Montreal 10
Norwalk 10
Santa Clara 10
Turku 10
Ankara 9
Brooklyn 9
Hanover 9
Manchester 9
Orem 9
Amsterdam 8
Denver 8
Johannesburg 8
Stockholm 8
Boston 7
Cingoli 7
Falls Church 7
Pune 7
Vienna 7
Atlanta 6
Columbus 6
Fayetteville 6
Monte San Pietrangeli 6
Bari 5
Belo Horizonte 5
Campinas 5
Montesilvano Marina 5
Mugnano di Napoli 5
Phoenix 5
San Francisco 5
Tampa 5
Tokyo 5
Bologna 4
Brasília 4
Cagliari 4
Cape Town 4
Chennai 4
Da Nang 4
Fano 4
Frankfurt am Main 4
Hortolândia 4
Jinhua 4
Karachi 4
Kilburn 4
Ottawa 4
Piracicaba 4
Senigallia 4
Totale 6.057
Nome #
Antimicrobial Resistance: A Challenge for the Future 263
A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital 171
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 155
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 153
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 153
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor 145
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 140
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 134
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 124
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 123
Hepatitis E in a region of Italy: An emerging autochthonous infection? 123
Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy 122
High prevalence of carbapenem-resistant Klebsiella pneumoniae ST307 recovered from faecal samples in an Italian hospital 121
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 118
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. 118
Tocilizumab in COVID-19 interstitial pneumonia 118
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 117
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 116
Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19 112
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 111
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 110
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 109
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 108
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 107
First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid 100
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 98
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 98
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 97
A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings 96
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. 95
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 94
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 93
Analisi della regione tet(O)-mef(A) in un elemento orf3-negativo di Streptococcus pyogenes. 92
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan 90
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 90
Quantitative molecular methods in virology. 89
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 89
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 89
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 89
Quantitative PCR and RT-PCR in virology. 86
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 86
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 85
A statistical model based on serological parameters for predicting occult HBV infection: implications for organ/ blood donations 85
42. Adenoviridae 84
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 84
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 84
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 82
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 81
Eritromicino-resistenza da efflusso in ceppi tetraciclino-sensibili (Tcs) e tetraciclino-resistenti (Tcr) di Streptococcus pyogenes. 81
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. 81
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 81
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 81
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 80
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 79
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques 79
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 78
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 77
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 76
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment 76
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. 75
Clearance of HIV-1 viraemia after seroconversion. 75
Long-term follow-up of acute hepatitis B: New insights in its natural history and implications for antiviral treatment 72
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants 71
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 71
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 70
Human papillomavirus infections: new perspectives for prevention and treatment. 68
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus. 68
Immune response, rather than sensitivity to entecavir, may determine the rate of viral decay upon treatment initiation in patients with chronic HBV infection 68
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 68
Comparison of HIV-1 recombinant phenotypic assays and virtual phenotype in the definition of coreceptor usage 68
Weak cross-lineage neutralization by anti sars-cov-2 spike antibodies after natural infection or vaccination is rescued by repeated immunological stimulation 68
Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. 67
Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. 67
Autochthonous dengue outbreak in Marche Region, Central Italy, August to October 2024 66
European Patent n° EPO 99830776.3: Method to evaluate the HIV drug sensitivity 65
Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. 65
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 65
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. 65
The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining 65
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 64
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 63
Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro. 63
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. 63
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system 62
Viral dynamics and mutations in the pol gene during primary HIV-1 infection. 62
Simple and reliable method to quantify the hepatitis B viral load and replicative capacity in liver tissue and blood leukocytes 62
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy. 61
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. 61
Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. 61
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis). 60
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. 60
Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. 59
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy. 58
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. 58
Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus. 58
Serological response after anti-SARS-CoV-2 BNT162b2 vaccine in IBD patients on biological therapy: a monocentric case-control study 57
Intra-host evolution of human immunodeficiency virus type 1 and viral fitness. 57
Infezione da Borrelia Burgdorferi e linfomi cutanei a cellule B nella regione marche 56
The introduction of the fusion inhibitors in the HAART-regimens. 56
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 56
Totale 8.820
Categoria #
all - tutte 51.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021805 0 0 0 0 0 86 134 110 139 123 150 63
2021/2022882 83 211 13 24 10 53 56 58 67 58 68 181
2022/20231.545 136 116 124 113 117 393 10 72 330 6 99 29
2023/2024820 134 16 50 118 167 151 8 40 13 13 17 93
2024/20251.725 205 149 84 10 55 50 175 67 472 132 145 181
2025/20261.717 276 278 236 390 458 79 0 0 0 0 0 0
Totale 9.600